Skip to main content

Panbela Therapeutics, Inc. (PBLA)

NASDAQ: PBLA · IEX Real-Time Price · USD
1.97 0.06 (3.14%)
Nov 26, 2021 1:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017201620152014201320122011
Revenue
00000000.971.230.7
Revenue Growth
--------21.00%76.16%-
Cost of Revenue
00000000.560.690.55
Gross Profit
00000000.420.540.15
Selling, General & Admin
3.251.972.113.422.662.591.080.20.150.16
Research & Development
2.512.351.782.592.52.852.370.2800
Other Operating Expenses
00000000.130.110.09
Operating Expenses
5.754.323.896.025.175.443.450.610.260.25
Operating Income
-5.75-4.32-3.89-6.02-5.17-5.44-3.45-0.190.28-0.1
Interest Expense / Income
0.022.191.811.620.180.180.180.040.040.03
Other Expense / Income
-0.710.10.453.280.110.060.01-0.02-0-0
Pretax Income
-5.06-6.62-6.16-10.91-5.45-5.68-3.64-0.210.25-0.14
Income Tax
-0.3-0.42-0.25-0.54-0.34-0.76-0.11000
Net Income
-4.77-6.2-5.91-10.37-5.11-4.93-3.53-0.210.25-0.14
Net Income Common
-4.77-6.2-5.91-10.37-5.11-4.93-3.53-0.210.25-0.14
Shares Outstanding (Basic)
8654311000
Shares Outstanding (Diluted)
8654311000
Shares Change
35.66%22.27%30.73%14.78%120.76%175.42%252.31%0.00%0.00%-
EPS (Basic)
-0.62-1.09-1.27-2.91-1.65-3.50-6.90-1.501.70-1.00
EPS (Diluted)
-0.62-1.09-1.27-2.91-1.65-3.50-6.90-1.501.70-1.00
Free Cash Flow Per Share
-0.50-0.48-0.51-0.95-0.77-2.77-6.54-279.28255.90-569.31
Gross Margin
-------42.65%43.88%21.32%
Operating Margin
--------19.95%22.94%-14.93%
Profit Margin
--------21.77%20.07%-19.77%
Free Cash Flow Margin
--------4159.42%3010.70%-11799.56%
Effective Tax Rate
5.83%6.27%4.12%4.91%6.25%13.30%2.97%-0.10%0.11%-0.08%
EBITDA
-5.05-4.42-4.35-9.29-5.27-5.5-3.468.625.923
EBITDA Margin
-------884.98%480.23%428.16%
EBIT
-5.05-4.42-4.35-9.29-5.27-5.5-3.46-0.180.28-0.1
EBIT Margin
--------18.06%23.02%-14.85%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).